InsidersTradesSigma
Total declarations
Companies
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
1
Disclosed sells
0
T+90 hit rate
75%
T+90 mean return
+9.1%
Across 4 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the detailed record of transactions filed by Lynch Karen S, Chief Executive Officer. Insider active across 4 companies, notably CVS HEALTH Corp. Cumulatively, 13 disclosures have been logged. Breakdown: 1 buy · 0 sell. Total volume traded: €882k. History available since 28 November 2021. The latest transaction was disclosed on 12 November 2025 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Declarations13 total
1,453 shares0Common StockSEC:0001225208-25-009210:0
565 shares0Common StockSEC:0000097745-25-000057:0
95 shares0Common StockSEC:0001127602-25-006219:0
45,248 shares@ US$79.5614.2% of flowCommon Stock (Restricted)SEC:0001127602-24-012256:0
136,640 shares0Common StockSEC:0001127602-24-005068:0
14,000 shares@ US$69.75483.7% of flowCommon Stock (By Trust)SEC:0001127602-23-014615:0
Canonical exit: 1 Aug 2023 (T+90)
93,677 shares@ US$74.3127.0% of flowCommon StockSEC:0001127602-23-012242:0
206,610 shares0Common StockSEC:0001127602-23-003331:0
116,940 shares@ US$101.090.0087% mcap82.2% of flowCommon StockSEC:0001127602-22-011633:0
257,916 shares0Common StockSEC:0001127602-22-006296:0
14,121 shares@ US$91.520.0009% mcap8.9% of flowCommon StockSEC:0001127602-21-029913:0
40,500 sharesCommon StockSEC:0001122304-16-000193:0
18,024 sharesCommon StockSEC:0001122304-16-000193:1
13 of 13 declarations
About Lynch Karen S
Karen S. Lynch serves as President and CEO of CVS Health Corp. She leads the company's operations and is responsible for the overall strategy. Her leadership is essential in advancing CVS Health's mission to improve community health. With extensive experience in the healthcare sector, Ms. Lynch plays a key role in innovation and enhancing healthcare services.
